Do Nitrosative Stress Molecules Hold Promise as Biomarkers for Multiple Sclerosis?

Area of Science:

• Neuroimmunology
• Neurology
• Biomarker Discovery

Background:

• Multiple sclerosis (MS) is a complex CNS autoimmune disease with inflammatory and neurodegenerative aspects.
• Biomarker-based characterization of MS clinical and non-clinical features is still developing.
• Neurofilament light chain (NfL) is a promising biomarker, but its variability limits clinical use.

Purpose of the Study:

• To evaluate the potential of glial fibrillary acidic protein (GFAP) as an additional biomarker to improve MS specificity.
• To explore nitrosative stress markers (nitrate, nitrite, 3NT) as novel biomarkers for MS.

Main Methods:

• Analysis of NfL and GFAP levels in relation to MS disease progression.
• Investigation of nitrosative stress markers including nitrate, nitrite, and nitrotyrosine (3NT).

Main Results:

• Increased levels of both NfL and GFAP were more frequently associated with MS progression than NfL alone.
• This suggests that combined biomarkers can offer improved specificity for MS.
• Nitrosative stress markers are proposed as potential additions to enhance current biomarker panels.

Conclusions:

• GFAP shows potential as an adjunctive marker to NfL for improved MS characterization.
• Nitrosative stress markers represent a promising avenue for future MS biomarker research.
• Developing comprehensive biomarker panels is crucial for better understanding and managing MS.